The Enterprise Value as of November 2024 (TTM) for Marizyme, Inc. (MRZM) is 27.04M

According to Marizyme, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.04M. This represents a change of -8.87% compared to the average of 29.67M of the last 4 quarters.

Marizyme, Inc. (MRZM) Historical Enterprise Value (quarterly & annually)

How has MRZM Enterprise Value performed in the past?

The mean historical Enterprise Value of Marizyme, Inc. over the last ten years is 20.09M. The current 27.04M Enterprise Value has changed 13.36% with respect to the historical average. Over the past ten years (40 quarters), MRZM's Enterprise Value was at its highest in in the June 2022 quarter at 110.53M. The Enterprise Value was at its lowest in in the December 2017 quarter at -31983.66.

Marizyme, Inc. (MRZM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Marizyme, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Marizyme, Inc. (MRZM) Average Enterprise Value

How has MRZM Enterprise Value performed in the past?

The current Enterprise Value of Marizyme, Inc. (MRZM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Marizyme, Inc. (MRZM) Enterprise Value vs. Peers

How is MRZM’s Enterprise Value compared to its peers?

Marizyme, Inc.’s Enterprise Value is less than NRx Pharmaceuticals, Inc. (0), greater than RenovaCare, Inc. (20.26M), greater than Aerovate Therapeutics, Inc. (8.73K), less than Scopus BioPharma Inc. (46.23M), less than Magenta Therapeutics, Inc. (0), less than Allena Pharmaceuticals, Inc. (0), greater than Akari Therapeutics, Plc (-111950.00), greater than Armata Pharmaceuticals, Inc. (-114170976.00), greater than Anebulo Pharmaceuticals, Inc. (-29461000.00), greater than Processa Pharmaceuticals, Inc. (17.47M), less than Inhibikase Therapeutics, Inc. (138.55M), less than Sio Gene Therapies Inc. (36.46M), greater than Kaleido Biosciences, Inc. (15.28K), less than Tempest Therapeutics, Inc. (154.45M), greater than null (-61213000.00), greater than null (4.26K), less than null (35.14M),

Build a custom stock screener for Marizyme, Inc. (MRZM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marizyme, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Marizyme, Inc. (MRZM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Marizyme, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.